- Home
- LYB vs LH Comparison
LYB vs LH Comparison
Compare LYB & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- LH
- Stock Information
- Founded
- LYB 1955
- LH 1971
- Country
- LYB United States
- LH United States
- Employees
- LYB N/A
- LH N/A
- Industry
- LYB Major Chemicals
- LH Medical Specialities
- Sector
- LYB Industrials
- LH Health Care
- Exchange
- LYB Nasdaq
- LH Nasdaq
- Market Cap
- LYB 20.3B
- LH 22.2B
- IPO Year
- LYB N/A
- LH N/A
- Fundamental
- Price
- LYB $53.38
- LH $270.43
- Analyst Decision
- LYB Hold
- LH Strong Buy
- Analyst Count
- LYB 14
- LH 13
- Target Price
- LYB $65.71
- LH $290.00
- AVG Volume (30 Days)
- LYB 5.9M
- LH 727.5K
- Earning Date
- LYB 08-01-2025
- LH 07-24-2025
- Dividend Yield
- LYB 10.27%
- LH 1.07%
- EPS Growth
- LYB N/A
- LH 72.08
- EPS
- LYB 0.77
- LH 9.07
- Revenue
- LYB $38,655,000,000.00
- LH $13,483,800,000.00
- Revenue This Year
- LYB N/A
- LH $10.76
- Revenue Next Year
- LYB $2.80
- LH $4.82
- P/E Ratio
- LYB $115.30
- LH $29.82
- Revenue Growth
- LYB 2.98
- LH 7.98
- 52 Week Low
- LYB $47.55
- LH $209.38
- 52 Week High
- LYB $99.36
- LH $283.47
- Technical
- Relative Strength Index (RSI)
- LYB 43.64
- LH 62.20
- Support Level
- LYB $47.55
- LH $258.36
- Resistance Level
- LYB $52.88
- LH $272.66
- Average True Range (ATR)
- LYB 2.41
- LH 4.32
- MACD
- LYB -0.16
- LH 0.96
- Stochastic Oscillator
- LYB 38.20
- LH 86.04
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.